ARTICLE SUMMARY:
Trump’s controversial picks for key US health posts don't necessarily portend disaster for federal medtech policies, according to leading industry advocates speaking at our recent Innovation Summit. EU health ministers present a broad-based MDR/IVDR reform package; China’s medtech market has changed, but opportunities remain; CMS unveils positive payment policies for pain management devices; and a look at newly published standards across the industry.
